OBJECTIVES: To investigate the association between environmental tobacco smoke, plasma cotinine concentration, and respiratory cancer or death. DESIGN: Nested case-control study within the European prospective investigation into cancer and nutrition (EPIC). PARTICIPANTS: 303,020 people from the EPIC cohort (total 500,000) who had never smoked or who had stopped smoking for at least 10 years, 123,479 of whom provided information on exposure to environmental tobacco smoke. Cases were people who developed respiratory cancers or died from respiratory conditions. Controls were matched for sex, age (plus or minus 5 years), smoking status, country of recruitment, and time elapsed since recruitment. MAIN OUTCOME MEASURES: Newly diagnosed cancer of lung, pharynx, and larynx; deaths from chronic obstructive pulmonary disease or emphysema. Plasma cotinine concentration was measured in 1574 people. RESULTS: Over seven years of follow up, 97 people had newly diagnosed lung cancer, 20 had upper respiratory cancers (pharynx, larynx), and 14 died from chronic obstructive pulmonary disease or emphysema. In the whole cohort exposure to environmental tobacco smoke was associated with increased risks (hazard ratio 1.30, 95% confidence interval 0.87 to 1.95, for all respiratory diseases; 1.34, 0.85 to 2.13, for lung cancer alone). Higher results were found in the nested case-control study (odds ratio 1.70, 1.02 to 2.82, for respiratory diseases; 1.76, 0.96 to 3.23, for lung cancer alone). Odds ratios were consistently higher in former smokers than in those who had never smoked; the association was limited to exposure related to work. Cotinine concentration was clearly associated with self reported exposure (3.30, 2.07 to 5.23, for detectable/non-detectable cotinine), but it was not associated with the risk of respiratory diseases or lung cancer. Frequent exposure to environmental tobacco smoke during childhood was associated with lung cancer in adulthood (hazard ratio 3.63, 1.19 to 11.11, for daily exposure for many hours). CONCLUSIONS: This large prospective study, in which the smoking status was supported by cotinine measurements, confirms that environmental tobacco smoke is a risk factor for lung cancer and other respiratory diseases, particularly in ex-smokers.
OBJECTIVES: To investigate the association between environmental tobacco smoke, plasma cotinine concentration, and respiratory cancer or death. DESIGN: Nested case-control study within the European prospective investigation into cancer and nutrition (EPIC). PARTICIPANTS: 303,020 people from the EPIC cohort (total 500,000) who had never smoked or who had stopped smoking for at least 10 years, 123,479 of whom provided information on exposure to environmental tobacco smoke. Cases were people who developed respiratory cancers or died from respiratory conditions. Controls were matched for sex, age (plus or minus 5 years), smoking status, country of recruitment, and time elapsed since recruitment. MAIN OUTCOME MEASURES: Newly diagnosed cancer of lung, pharynx, and larynx; deaths from chronic obstructive pulmonary disease or emphysema. Plasma cotinine concentration was measured in 1574 people. RESULTS: Over seven years of follow up, 97 people had newly diagnosed lung cancer, 20 had upper respiratory cancers (pharynx, larynx), and 14 died from chronic obstructive pulmonary disease or emphysema. In the whole cohort exposure to environmental tobacco smoke was associated with increased risks (hazard ratio 1.30, 95% confidence interval 0.87 to 1.95, for all respiratory diseases; 1.34, 0.85 to 2.13, for lung cancer alone). Higher results were found in the nested case-control study (odds ratio 1.70, 1.02 to 2.82, for respiratory diseases; 1.76, 0.96 to 3.23, for lung cancer alone). Odds ratios were consistently higher in former smokers than in those who had never smoked; the association was limited to exposure related to work. Cotinine concentration was clearly associated with self reported exposure (3.30, 2.07 to 5.23, for detectable/non-detectable cotinine), but it was not associated with the risk of respiratory diseases or lung cancer. Frequent exposure to environmental tobacco smoke during childhood was associated with lung cancer in adulthood (hazard ratio 3.63, 1.19 to 11.11, for daily exposure for many hours). CONCLUSIONS: This large prospective study, in which the smoking status was supported by cotinine measurements, confirms that environmental tobacco smoke is a risk factor for lung cancer and other respiratory diseases, particularly in ex-smokers.
Authors: P Vineis; M Alavanja; P Buffler; E Fontham; S Franceschi; Y T Gao; P C Gupta; A Hackshaw; E Matos; J Samet; F Sitas; J Smith; L Stayner; K Straif; M J Thun; H E Wichmann; A H Wu; D Zaridze; R Peto; R Doll Journal: J Natl Cancer Inst Date: 2004-01-21 Impact factor: 13.506
Authors: W P Bennett; M C Alavanja; B Blomeke; K H Vähäkangas; K Castrén; J A Welsh; E D Bowman; M A Khan; D B Flieder; C C Harris Journal: J Natl Cancer Inst Date: 1999-12-01 Impact factor: 13.506
Authors: N Malats; A M Camus-Radon; F Nyberg; W Ahrens; V Constantinescu; A Mukeria; S Benhamou; H Batura-Gabryel; I Bruske-Hohlfeld; L Simonato; A Menezes; S Lea; M Lang; P Boffetta Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-08 Impact factor: 4.254
Authors: S S Hecht; M Ye; S G Carmella; A Fredrickson; J L Adgate; I A Greaves; T R Church; A D Ryan; S J Mongin; K Sexton Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-11 Impact factor: 4.254
Authors: E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Yael Strulovici-Barel; Larsson Omberg; Michael O'Mahony; Cynthia Gordon; Charleen Hollmann; Ann E Tilley; Jacqueline Salit; Jason Mezey; Ben-Gary Harvey; Ronald G Crystal Journal: Am J Respir Crit Care Med Date: 2010-08-06 Impact factor: 21.405
Authors: Margaret W Gerbase; Christian Schindler; Jean-Pierre Zellweger; Nino Künzli; Sara H Downs; Otto Brändli; Joel Schwartz; Martin Frey; Luc Burdet; Thierry Rochat; Ursula Ackermann-Liebrich; Philippe Leuenberger Journal: Am J Respir Crit Care Med Date: 2006-08-24 Impact factor: 21.405
Authors: Susan E Olivo-Marston; Ping Yang; Leah E Mechanic; Elise D Bowman; Sharon R Pine; Christopher A Loffredo; Anthony J Alberg; Neil Caporaso; Peter G Shields; Stephen Chanock; Yanhong Wu; Ruoxiang Jiang; Julie Cunningham; Jin Jen; Curtis C Harris Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254
Authors: Jesse D Troy; Jennifer R Grandis; Ada O Youk; Brenda Diergaarde; Marjorie Romkes; Joel L Weissfeld Journal: Cancer Epidemiol Date: 2013-04-22 Impact factor: 2.984